Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $5 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 83.6%

Neg 0% Neu 83.6% Pos 0%

Cantor Fitzgerald analyst Sarah James reiterates Nano X Imaging (NASDAQ:NNOX) with a Overweight and maintains $5 price target.